Viewing StudyNCT00485277



Ignite Creation Date: 2024-05-05 @ 5:36 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00485277
Status: COMPLETED
Last Update Posted: 2019-03-14
First Post: 2007-06-08

Brief Title: A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2 Metastatic Breast Cancer
Sponsor: Bavarian Nordic
Organization: Bavarian Nordic

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
HER-2 Positive Metastatic Breast Cancer View
Breast cancer View
Vaccine View
Metastatic View
HER-2-positive View
Phase I View